These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 18076687)

  • 1. Effects of oral isotretinoin therapy on peripheral nerve functions.
    Chroni E; Pasmatzi E; Monastirli A; Georgiou S; Polychronopoulos P; Tsambaos D
    Clin Exp Dermatol; 2008 Mar; 33(2):191-2. PubMed ID: 18076687
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of oral isotretinoin therapy on peripheral nerve functions: a preliminary study. Reply from author.
    Aydogan K; Karli N
    Clin Exp Dermatol; 2008 Jul; 33(4):507-8. PubMed ID: 18355364
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of oral isotretinoin therapy on peripheral nerve functions: a preliminary study.
    Aydogan K; Karli N
    Clin Exp Dermatol; 2007 Jan; 32(1):81-4. PubMed ID: 17032316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mid-term oral isotretinoin therapy causes a predominantly sensory demyelinating neuropathy.
    Altun Y; Inan E
    Ideggyogy Sz; 2019 May; 72(5-6):159-164. PubMed ID: 31241259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral isotretinoin, neuropathy and hypovitaminosis A.
    Danby FW
    Clin Exp Dermatol; 2008 Mar; 33(2):190. PubMed ID: 17714528
    [No Abstract]   [Full Text] [Related]  

  • 6. Solid facial edema: treatment failure with oral isotretinoin monotherapy and combination oral isotretinoin and oral steroid therapy.
    Patel AB; Harting MS; Hsu S
    Dermatol Online J; 2008 Jan; 14(1):14. PubMed ID: 18319031
    [No Abstract]   [Full Text] [Related]  

  • 7. Night blindness following low-dose isotretinoin.
    Halpagi P; Grigg J; Klistorner A; Damian DL
    J Eur Acad Dermatol Venereol; 2008 Jul; 22(7):893-4. PubMed ID: 18031494
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute acne flare following isotretinoin administration: potential protective role of low starting dose.
    Borghi A; Mantovani L; Minghetti S; Virgili A; Bettoli V
    Dermatology; 2009; 218(2):178-80. PubMed ID: 19060474
    [No Abstract]   [Full Text] [Related]  

  • 9. Changes of psychiatric parameters and their relationships by oral isotretinoin in acne patients.
    Hahm BJ; Min SU; Yoon MY; Shin YW; Kim JS; Jung JY; Suh DH
    J Dermatol; 2009 May; 36(5):255-61. PubMed ID: 19382995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term oral isotretinoin therapy does not cause clinical or subclinical peripheral neuropathy.
    Chroni E; Pasmatzi E; Monastirli A; Georgiou S; Katsoulas G; Polychronopoulos P; Tsambaos D
    J Dermatolog Treat; 2006; 17(1):6-8. PubMed ID: 16467017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conjunctival impression cytology, ocular surface, and tear-film changes in patients treated with systemic isotretinoin.
    Karalezli A; Borazan M; Altinors DD; Dursun R; Kiyici H; Akova YA
    Cornea; 2009 Jan; 28(1):46-50. PubMed ID: 19092405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral side effects of isotretinoin chronic intake.
    Rodrigues MT; Albuquerque DF; Capelozza AL; Faria FA; Santos CF
    N Y State Dent J; 2008; 74(4):36-9. PubMed ID: 18788179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquired port wine stain following oral isotretinoin.
    Hoque S; Holden C
    Clin Exp Dermatol; 2005 Sep; 30(5):587-8. PubMed ID: 16045705
    [No Abstract]   [Full Text] [Related]  

  • 14. Oral isotretinoin, neuropathy and hypovitaminosis A.
    Danby FW
    Clin Exp Dermatol; 2009 Oct; 34(7):e260. PubMed ID: 19438530
    [No Abstract]   [Full Text] [Related]  

  • 15. Is oral isotretinoin the treatment of choice in moderate and severe inflammatory acne vulgaris?
    Verros CD; Rallis E
    J Eur Acad Dermatol Venereol; 2007 Oct; 21(9):1270-1. PubMed ID: 17894728
    [No Abstract]   [Full Text] [Related]  

  • 16. Hoarseness during isotretinoin therapy.
    Busso CI; Serrano RL
    J Am Acad Dermatol; 2005 Jan; 52(1):168. PubMed ID: 15627106
    [No Abstract]   [Full Text] [Related]  

  • 17. [Rhabdomyolysis during isotretinoin therapy].
    Gómez-Bernal S; Rodríguez-Pazos L; Rodríguez-Granados MT; Toribio J
    Actas Dermosifiliogr; 2011 Jun; 102(5):390-1. PubMed ID: 21392729
    [No Abstract]   [Full Text] [Related]  

  • 18. Genetic vulnerability and isotretinoin-induced psychiatric adverse events.
    Kontaxakis VP; Ferentinos PP; Havaki-Kontaxaki BJ; Papadimitriou GN
    World J Biol Psychiatry; 2010 Mar; 11(2):158-9. PubMed ID: 20109108
    [No Abstract]   [Full Text] [Related]  

  • 19. Menstrual irregularity during isotretinoin treatment.
    Kwon HJ; Lee JY; Cho BK; Park HJ
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):562-3. PubMed ID: 17374003
    [No Abstract]   [Full Text] [Related]  

  • 20. Isotretinoin: stroke and myocardial infarction?
    Prescrire Int; 2007 Jun; 16(89):113. PubMed ID: 17590908
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.